GALT Antibodies

Santa Cruz Biotechnology features a diverse variety of GALT Antibodies for investigating galactose-1-phosphate uridylyltransferase (GALT) protein. GALT Antibodies are available for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GALT plays a crucial role in the metabolism of galactose, converting galactose-1-phosphate into glucose-1-phosphate, which is essential for energy production and cellular function. Deficiencies in GALT can lead to galactosemia, a serious metabolic disorder that can cause severe complications if not managed properly. Understanding the function and regulation of GALT is vital for developing therapeutic strategies for related metabolic disorders. Researchers worldwide utilize GALT monoclonal antibodies to advance their studies in galactose metabolism pathways. Current investigations focus on identifying novel therapeutic targets and biomarkers for early detection of GALT-related disorders. Exploring GALT's role in various cellular processes continues to reveal new insights into metabolic regulation and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in advancing our understanding of GALT's role in human health and disease.